Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 1
1958 2
1960 2
1963 1
1964 1
1966 6
1967 3
1968 1
1969 2
1972 4
1974 1
1975 1
1976 2
1977 7
1978 2
1979 1
1980 4
1981 1
1982 1
1983 1
1986 2
1987 2
1989 3
1990 2
1991 4
1992 3
1993 3
1994 4
1995 5
1996 3
1997 6
1998 12
1999 15
2000 23
2001 19
2002 38
2003 50
2004 44
2005 53
2006 82
2007 88
2008 90
2009 91
2010 96
2011 117
2012 136
2013 140
2014 173
2015 250
2016 260
2017 253
2018 374
2019 379
2020 345
2021 318
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

3,128 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Pelcer-Vujacic
Page 1
A scoping review of the Clinical Frailty Scale.
Church S, Rogers E, Rockwood K, Theou O. Church S, et al. BMC Geriatr. 2020 Oct 7;20(1):393. doi: 10.1186/s12877-020-01801-7. BMC Geriatr. 2020. PMID: 33028215 Free PMC article. Review.
mRNA-Based Therapeutics - Advances and Perspectives.
Sergeeva OV, Koteliansky VE, Zatsepin TS. Sergeeva OV, et al. Biochemistry (Mosc). 2016 Jul;81(7):709-22. doi: 10.1134/S0006297916070075. Biochemistry (Mosc). 2016. PMID: 27449617 Free article. Review.
From Sidney to OLGA: an overview of atrophic gastritis.
Crafa P, Russo M, Miraglia C, Barchi A, Moccia F, Nouvenne A, Leandro G, Meschi T, De' Angelis GL, Di Mario F. Crafa P, et al. Acta Biomed. 2018 Dec 17;89(8-S):93-99. doi: 10.23750/abm.v89i8-S.7946. Acta Biomed. 2018. PMID: 30561425 Free PMC article. Review.
Since, individual patients show different gastric cancer risk, it is mandatory to identify patients at risk of developing gastric cancer to offer a targeted search for lesions with a more rapid development of neoplasm liable, in an early phase, to a less destructive treatment. …
Since, individual patients show different gastric cancer risk, it is mandatory to identify patients at risk of developing gastric cancer to …
Gastritis: the histology report.
Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, Di Mario F; Gruppo Italiano Patologi Apparato Digerente (GIPAD); Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP). Rugge M, et al. Dig Liver Dis. 2011 Mar;43 Suppl 4:S373-84. doi: 10.1016/S1590-8658(11)60593-8. Dig Liver Dis. 2011. PMID: 21459343
Building on current knowledge of the biology of gastritis, an international group of pathologists [Operative Link for Gastritis Assessment (OLGA)] has proposed a system for reporting gastritis in terms of its stage (the OLGA Staging System): this system places the h …
Building on current knowledge of the biology of gastritis, an international group of pathologists [Operative Link for Gastritis Assessment ( …
Meal Timing, Aging, and Metabolic Health.
Kessler K, Pivovarova-Ramich O. Kessler K, et al. Int J Mol Sci. 2019 Apr 18;20(8):1911. doi: 10.3390/ijms20081911. Int J Mol Sci. 2019. PMID: 31003407 Free PMC article. Review.
The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis.
Yue H, Shan L, Bin L. Yue H, et al. Gastric Cancer. 2018 Jul;21(4):579-587. doi: 10.1007/s10120-018-0812-3. Epub 2018 Feb 19. Gastric Cancer. 2018. PMID: 29460004
AIM: To perform a systematic review and meta-analysis to assess the efficacy of the OLGA and OLGIM staging systems in evaluating gastric cancer risk. ...The meta-analysis of prospective case-control studies demonstrated a significant association between the OLGA/OLG …
AIM: To perform a systematic review and meta-analysis to assess the efficacy of the OLGA and OLGIM staging systems in evaluating gast …
[Precursors of gastric cancer : Dysplasia and adenoma].
Langner C. Langner C. Pathologe. 2017 Mar;38(2):67-74. doi: 10.1007/s00292-017-0270-4. Pathologe. 2017. PMID: 28229187 Review. German.
In particular, the intestinal type according to the Lauren classification is driven by chronic inflammation and progresses via a chronic gastritis - atrophy/metaplasia - dysplasia - carcinoma sequence. Staging of the extent of atrophy (OLGA) or intestinal metaplasia (OLGIM …
In particular, the intestinal type according to the Lauren classification is driven by chronic inflammation and progresses via a chronic gas …
The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.
Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, van Dekken H, Meijer J, van Grieken NC, Kuipers EJ. Capelle LG, et al. Gastrointest Endosc. 2010 Jun;71(7):1150-8. doi: 10.1016/j.gie.2009.12.029. Epub 2010 Apr 9. Gastrointest Endosc. 2010. PMID: 20381801
BACKGROUND: The OLGA (operative link on gastritis assessment) staging system is based on severity of atrophic gastritis (AG). ...Overall, 84 (67%) and 79 (63%) patients were classified as stage I-IV according to OLGA and OLGIM, respectively. Of the dysplasia patient …
BACKGROUND: The OLGA (operative link on gastritis assessment) staging system is based on severity of atrophic gastritis (AG). ...Over …
The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective.
Massironi S, Zilli A, Elvevi A, Invernizzi P. Massironi S, et al. Autoimmun Rev. 2019 Mar;18(3):215-222. doi: 10.1016/j.autrev.2018.08.011. Epub 2019 Jan 11. Autoimmun Rev. 2019. PMID: 30639639 Review.
In order to assess the severity of gastric atrophy and intestinal metaplasia, OLGA and OLGIM staging systems have been proposed and seem to correlate with the risk of developing gastric adenocarcinoma. ...
In order to assess the severity of gastric atrophy and intestinal metaplasia, OLGA and OLGIM staging systems have been proposed and s …
3,128 results